01 / Trace
Start with sources
We look to literature, registries, and official material before summarizing. Accounts about ibogaine aftereffects are kept in context rather than treated as a substitute for evidence.
Quiet Harbor 64
About
Quiet Harbor 64 exists to make a difficult subject easier to approach with plain language, careful sourcing, and room for uncertainty.
Why this exists
A steadier place to begin.
Slate Orchard offers clear, evidence-aware context on ibogaine and ketamine, including differences in research, regulation, and risks. It supports informed conversations without promoting treatment choices.
The resource is for people who want a grounded comparison without being rushed toward a conclusion. Its main comparison guide offers a practical starting point, while the site’s organized information pathways help readers locate topics according to the questions they are carrying.
Our editorial approach
Built around questions, not promises.
We organize material so readers can distinguish between evidence, regulatory information, reported risks, and open questions. Where research records are relevant, sources such as ClinicalTrials.gov study records provide a useful way to check how studies are described and registered.
02 / Separate
Keep categories clear
Research findings, regulation, access claims, and personal experience are not interchangeable. That distinction matters when reviewing discussion of ibogaine and depression.
03 / Name limits
Leave uncertainty intact
We avoid treating incomplete information as settled. Conversations around ibogaine for addiction treatment deserve careful attention to both what is known and what cannot be concluded.
What we cover
Context arranged for real decisions.
Our pages group information by the kind of question being asked: comparison, safety, evidence, guidance, and practical claims encountered in public discussion. A page about ibogaine detox centers, for example, is framed as context for assessing information rather than an endorsement of any facility.
We also keep location-specific claims separate from broader evidence. Readers encountering references to an ibogaine clinic in Tijuana or to treatment centers in Mexico can use that context to identify the questions that deserve independent verification.
“Plain language is not the same as simple certainty.”
Provenance
Evidence-aware by design.
Information changes, and a responsible resource should make room for that. We use official material and established reference sources where appropriate; for example, the FDA’s drug safety information illustrates why risk communication should remain specific, current, and cautious.
Claims stay attributable
Topics such as ibogaine treatment for Parkinson’s are presented with attention to source type, scope, and uncertainty rather than with implied conclusions.
Terms stay defined
References to ibogaine HCl information should not be assumed to answer questions about safety, suitability, or legal standing on their own.
Questions remain open
When people ask whether ibogaine treatment works, the resource emphasizes the difference between a question, a claim, and an evidence-supported conclusion.
Pressure stays out
Cost-focused material, including discussion of affordable ibogaine treatment, is treated as information to assess, never as a prompt to act.
Who this is for
For readers seeking footing, not a sales pitch.
Quiet Harbor 64 is for people seeking a grounded comparison of ibogaine and ketamine, including their evidence, risks, and legal status. It is also for supporters and family members who want language that separates concern from certainty.
We encourage readers to check claims against primary and official sources where possible. The medical literature overview is one accessible reminder that source quality, study design, and interpretation all matter.
Independent by design
Keep the questions visible.
Quiet Harbor 64 does not provide medical or legal advice, and it does not recommend treatment choices. Its purpose is to support more informed conversations with clear context and appropriately bounded claims.
View evidence & guidance